US2019024154A1PendingUtilityA1

Method and product for localized or spatial detection of nucleic acid in a tissue sample

77
Assignee: SPATIAL TRANSCRIPTOMICS ABPriority: Apr 13, 2011Filed: Jul 23, 2018Published: Jan 24, 2019
Est. expiryApr 13, 2031(~4.8 yrs left)· nominal 20-yr term from priority
C12Q 1/6841C12Q 1/6853C12N 15/11C12Q 1/6844C12Q 1/6837C12Q 1/6816C12Q 1/6876G16B 50/30C12Y 600/00G16B 50/20C12Q 1/6827C12Q 1/6806G16B 30/00C12Q 2565/514C12Q 2543/101C12Q 2565/537G01N 1/42G01N 1/30C12Q 1/682C12N 15/1065
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Localized detection of RNA in a tissue sample that includes cells is accomplished on an array. The array include a number of features on a substrate. Each feature includes a different capture probe immobilized such that the capture probe has a free 3′ end. Each feature occupies a distinct position on the array and has an area of less than about 1 mm 2 . Each capture probe is a nucleic acid molecule, which includes a positional domain including a nucleotide sequence unique to a particular feature, and a capture domain including a nucleotide sequence complementary to the RNA to be detected. The capture domain can be at a position 3′ of the positional domain.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for localized detection of DNA in a tissue sample comprising cells, said method comprising:
 (a) providing an array comprising a plurality of features on a substrate, each feature comprising a different capture probe immobilized thereon such that the capture probe has a free 3′ end, each feature occupying a distinct position on the array and having an area of less than about 1 mm 2 , each capture probe consisting of a nucleic acid molecule comprising the following domains oriented 5′ to 3′:   (i) a positional domain comprising a nucleotide sequence unique to a particular feature; and   (ii) a capture domain comprising a nucleotide sequence complementary to the DNA to be detected;   (b) contacting said array with the tissue sample comprising cells such that the tissue sample contacts a plurality of the features at their distinct positions on the array;   (c) hybridizing the DNA present in the tissue sample comprising cells that are complementary to the capture sequences of the capture probes immobilized on the features, such that the DNA is captured by the capture domain of the capture probes in the features;   (d) generating DNA molecules from the captured DNA by extending the capture probes enzymatically using: (i) the captured DNA as an extension or ligation template, such that the DNA molecules comprise the nucleotide sequences of the positional domains, or (ii) the capture probe as a ligation template, such that the DNA molecules comprise the nucleotide sequences complementary to the positional domains;   (e) releasing at least part of the DNA molecules from the features of the surface of the array, and   (f) identifying nucleotide sequences of the positional domain or sequences complementary to the nucleotide sequences of the positional domain present in the released DNA molecules, wherein the presence of the nucleotide sequence of the positional domain unique to a given particular feature or the sequence complementary to the nucleotide sequence of the positional domain unique to said particular feature indicates that the released DNA molecule was obtained from DNA present in the tissue sample comprising cells at the distinct position where the tissue sample comprising cells contacted said particular feature.   
     
     
         2 . The method of  claim 1 , further comprising a step of generating a complementary strand of the DNA molecules. 
     
     
         3 . The method of  claim 2 , wherein the step of releasing at least part of the DNA molecules from the surface of the array comprises releasing the complementary strands of the DNA molecules by denaturation. 
     
     
         4 . The method of  claim 3  further comprising a step of amplifying the released complementary strands of the DNA molecules. 
     
     
         5 . The method of  claim 1  further comprising a step of amplifying the DNA molecules such that the amplified DNA molecules comprise nucleotide sequences of the positional domains and nucleotide sequences complementary to the positional sequences. 
     
     
         6 . The method of  claim 5 , wherein said step of amplifying the DNA molecules functions as the step of releasing at least part of the DNA molecules from the features of the surface of the array. 
     
     
         7 . The method of  claim 1 , wherein each capture probe consisting of a nucleic acid molecule comprises the following domains oriented 5′ to 3′:
 (i) a cleavage domain; 
 (ii) a positional domain comprising a nucleotide sequence unique to a particular feature; and 
 (iii) a capture domain comprising a nucleotide sequence complementary to the DNA to be detected, 
 and wherein the step of releasing at least part of the DNA molecules from the features of the surface of the array comprises cleaving the cleavage domain. 
 
     
     
         8 . The method of  claim 7 , wherein the step of cleaving the cleavage domain comprises cleaving the cleavage domain with a cleavage enzyme that recognizes a nucleotide sequence in the cleavage domain and cleaves the DNA molecules at a position that is 5′ to the positional domain. 
     
     
         9 . The method of  claim 1 , wherein the DNA is genomic DNA. 
     
     
         10 . The method of  claim 1  further comprising a step of fragmenting DNA in the tissue sample comprising cells. 
     
     
         11 . The method of  claim 10 , wherein the step of fragmenting DNA is carried out before or after contacting the array with the tissue sample comprising cells. 
     
     
         12 . The method of  claim 1  further comprising a step of providing DNA in the tissue sample comprising cells with a binding domain that hybridizes to the capture domain of the capture probe. 
     
     
         13 . The method of  claim 12 , wherein the binding domain comprises a homopolymeric sequence. 
     
     
         14 . The method of  claim 13 , wherein the homopolymeric sequence is a poly-A sequence. 
     
     
         15 . The method of  claim 14 , wherein the capture domain comprises a poly-T sequence. 
     
     
         16 . The method of  claim 1 , wherein the capture domain comprises a random hexamer sequence. 
     
     
         17 . The method of  claim 1 , wherein in step (d)(ii) the capture probes are partially double stranded molecules comprising a first strand comprising the capture domain hybridized to a second strand, which is immobilized on the array surface by its 3′ end, and wherein the first strand templates the ligation of the captured DNA to the second strand. 
     
     
         18 . The method of  claim 1 , wherein step (f) comprises sequencing the released DNA molecules. 
     
     
         19 . The method of  claim 18  further comprising a step of correlating the sequence analysis information obtained in step (f) with an image of said tissue sample comprising cells, wherein the method includes a step of imaging the tissue sample comprising cells after step (b). 
     
     
         20 . The method of  claim 1 , further comprising determining which genes are present at a particular distinct location of the tissue sample comprising cells by a method comprising determining the sequences of the released DNA molecules comprising the same nucleotide sequence of a positional domain or sequence complementary the nucleotide sequence of a positional domain. 
     
     
         21 . The method of  claim 1 , further comprising determining where a particular gene is present in the tissue sample comprising cells by a method comprising identifying the released DNA molecules comprising a sequence associated with said particular gene and determining which nucleotide sequences of the positional domains or sequences complementary the nucleotide sequences of the positional domains are attached thereto. 
     
     
         22 . The method of  claim 1 , further comprising correlating the nucleotide sequence of a positional domain unique to a given particular feature or the sequence complementary to the nucleotide sequence of a positional domain unique to said particular feature present in the released DNA molecules to a position in the tissue sample. 
     
     
         23 . The method of  claim 1 , wherein the tissue sample comprising cells is a tissue section or a cell suspension. 
     
     
         24 . The method of  claim 1 , wherein the capture probes are immobilized on the substrate by a chemical linker. 
     
     
         25 . The method of  claim 1 , wherein the array is a bead array and the capture probes are immobilized on the beads of the array.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.